Type 2 diabetes and Inflammatory Bowel Disease: A Bidirectional Two-sample Mendelian Randomization Study

Author:

Xu Guangyi1,Xu Yanhong1,Zheng Taohua2,Liu Ting1

Affiliation:

1. Qingdao University

2. Affiliated Hospital of Qingdao University

Abstract

Abstract Background Studies have shown that patients with inflammatory bowel diseases (IBD) coexisting with type 2 diabetes mellitus (T2DM) have higher risk of infection, increased healthcare utilization and decreased quality of life, while currently they are not treated with more effective immunosuppressive therapy. Observational studies have shown a bidirectional association between T2DM and IBD, including Crohn's disease (CD) and ulcerative colitis (UC). However, because of the difficulty in determining sequential timeliness, it is unclear whether the observed associations are causal. We investigated the association between T2DM and IBD by bidirectional two-sample Mendelian randomization (MR) to clarify the casual relationship.Methods Independent genetic variants for T2DM and IBD were selected as instruments from published genome-wide association studies (GWAS), mainly in European ancestry. Instrumental variables (IVs) associated with T2DM and IBD were extracted separately from the largest GWAS meta-analysis. MR analyses included inverse variance weighting, weighted median estimator, MR Egger regression, and sensitivity analyses with Steiger filtering and MR PRESSO.Results Genetically predicted T2DM (per log-odds ratio increase) was associated with risk for IBD. In the data samples for UC (6968 cases, 20464 controls) and CD (5956 cases, 14927 controls), the odds ratio [95% confidence interval] for T2DM on UC and CD were 0.882 (0.826,0.942), and 0.955(0.877,1.038), respectively. In contrast, among 62,892 patients with T2DM, no genetically influenced association between IBD and T2DM was observed.Conclusions The results of the bidirectional MR Study suggest that T2DM has a negative causal effect on UC, which provides implications for clinical treatment decisions in IBD patients with T2DM. The findings do not support a causal relationship between T2DM and CD, UC and T2DM, or CD and T2DM, and the impact of IBD on T2DM needs further investigation.

Publisher

Research Square Platform LLC

Reference46 articles.

1. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies;Ng SC;Lancet Dec,2017

2. The Changing Epidemiology of Inflammatory Bowel Disease: What Goes Up May Come Down;Khalili H;Inflamm Bowel Dis Mar,2020

3. Epidemiology of inflammatory bowel disease in Asia;Yang SK;Inflamm Bowel Dis Aug,2001

4. The Burden of Inflammatory Bowel Disease in Europe in 2020;Zhao M;J Crohns Colitis Sep,2021

5. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences;Loftus EV;Gastroenterol May,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3